Cancer | Tumor Profiling Market 2017-2021 Type, Technique, Service, Technology

Cancer | Tumor Profiling Market 2017-2021 by Service spreads across 157 pages profiling 11 companies and supported with 81 tables and 34 figures available at rnrmarketresearch.com

Get Sample Copy Here @ https://goo.gl/QDSuHJ

The global Cancer | Tumor Profiling market is poised to reach USD 61.87 billion by 2021 from USD 25.82 billion in 2016, at a CAGR of 19.1% from 2016 to 2021. Increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research are the major factors driving the growth of the global Cancer |Tumor Profiling market.

In recent years, the Asia-Pacific market for cancer | tumor profiling has witnessed significant growth due to the rising incidence of cancer, increasing demand for better healthcare services in developing economies such as India and China, rising number of contract research organizations (CROs), and increasing focus of international players on emerging markets.
In this report, the global Cancer |Tumor Profiling market is segmented on the basis of technology, technique, application, and region. On the basis of technology, the global cancer | tumor profiling market is broadly divided into next-generation sequencing, quantitative PCR, in situ hybridization, immune his to chemistry, and microarray. The next-generation sequencing segment is expected to account for the largest share of the cancer | tumor profiling technology market in 2016. Factors contributing to its largest share include advantages such as reduction in sequencing costs, technology advancements in sequencing platforms, research laboratories and academicians promoting the use of NGS.

Cancer Profiling Market, By Application

Introduction
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications

Inquiry for Discount Here @ https://goo.gl/4JkTYv

Fundamentals of Table of Content:

7 Cancer Profiling Market, By Technique

7.1 Introduction
7.2 Genomics
7.3 Proteomics
7.4 Epigenetics
7.5 Metabolomics

8 Cancer Profiling Market, By Technology

8.1 Introduction
8.2 Next-Generation Sequencing (NGS)
8.3 Quantitative Polymerase Chain Reaction (QPCR)
8.4 Immunohistochemistry (ICH)
8.5 in Situ Hybridization (ISH)
8.5.1 Fluorescence in Situ Hybridization (FISH)
8.5.2 Chromogenic in Situ Hybridization (CISH)
8.6 Microarray

11 Company Profiles

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Illumina, Inc.
11.3 Qiagen N.V.
11.4 Neogenomics Laboratories, Inc.
11.5 HTG Molecular Diagnostics, Inc.
11.6 Genomic Health Inc.
11.7 Caris Life Sciences
11.8 Helomics Corporation
11.9 Nanostring Technologies, Inc.
11.10 Oxford Gene Technology
11.11 Ribomed Biotechnologies, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

About Company:
RnR Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website.

Contact Us:
RnR Market Research
Corporate Headquarters
2nd floor, metropole,
Bund garden road, Pune-411001.
+ 1 888 391 5441

This release was published on openPR.